INMUNE BIO INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INMUNE BIO INC. stock issued during period, value, other for the quarter ending 2026-06-30 was $584.00K.
- INMUNE BIO INC. stock issued during period, value, other for the quarter ending 2024-09-30 was $12.29M.
- INMUNE BIO INC. stock issued during period, value, other for the quarter ending 2024-06-30 was $13.46M.
- INMUNE BIO INC. stock issued during period, value, other for the quarter ending 2022-03-31 was $55.00K, a 5400.00% increase year-over-year.
- INMUNE BIO INC. stock issued during period, value, other for fiscal 2024 was $25.43M.
- INMUNE BIO INC. stock issued during period, value, other for fiscal 2021 was $619.00K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-06-30 | $584.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $25.43M 10-K · filed 2025-03-27 | |
| 2024-09-30 | $12.29M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $13.46M 10-Q · filed 2024-10-31 | |
| 2022-03-31 | $55.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $619.00K 10-K · filed 2023-03-02 | |
| 2021-06-30 | $619.00K 10-Q · filed 2022-11-02 | |
| 2021-03-31 | $1.00K 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |